The current status of virus-positive liver transplantation.

Abstract

PURPOSE OF REVIEW:

The last 2 years have seen significant developments in virus-positive liver transplantation. This review provides an updated account of the transplantation of hepatitis C virus (HCV), hepatitis B virus (HBV) and HIV-positive livers, with a specific focus on studies published in the last 18 months.

RECENT FINDINGS:

The advent of highly efficacious direct acting antiviral agents, nucleos(t)ide analogues and a continued organ shortage have led to the well tolerated utilization of HCV, HBV and HIV-positive organs. There has been a significant increase in the transplantation of HCV seropositive and NAT+ organs into HCV-negative recipients, without compromising patient or graft survival. Early reports of HBV core antibody (HBVcAb), HBV surface antigen (HBVsAg) positive and NAT+ donors are growing in the USA with promising results. Similarly, small studies have described the use of HIV-positive to HIV-positive liver transplantation without concerns for superinfection.

SUMMARY:

HCV, HBV and HIV-positive liver transplantations can be accomplished safely and are associated with equivalent outcomes when paired with appropriate recipients. The practice of virus positive liver transplantation should be encouraged to combat the ongoing organ shortage.

• Authors: Aaron M Delman, Allison M Ammann, Shimul A Shah
• Journal: Current opinion in organ transplantation (Curr Opin Organ Transplant) Vol. 26 Issue 2 Pg. 160-167 (04 01 2021) ISSN: 1531-7013 [Electronic] United States
• PMID: 33595981 (Publication Type: Journal Article, Review)
• Copyright: Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Chemical References

• Antiviral Agents

Topics

• Antiviral Agents (therapeutic use)
• Hepacivirus
• Hepatitis B
• Hepatitis C (drug therapy)
• Hepatitis C, Chronic
• Humans
• Liver Transplantation (adverse effects)
• Tissue Donors